Deepinder Goyal’s health-tech startup Temple has launched its first Employee Stock Ownership Plan (ESOP) liquidity program, allowing eligible current and former employees to sell a portion of their vested stock options. The initiative comes as the wearable technology startup’s valuation has climbed to approximately $375 million, nearly doubling from its $190 million valuation following its seed funding round earlier this year. The program is designed to reward early employees while enabling them to realize the value of their equity without waiting for an initial public offering (IPO) or acquisition.
Temple, founded by former Eternal (formerly Zomato) CEO Deepinder Goyal, is developing a next-generation wearable focused on monitoring cerebral blood flow and advanced physiological metrics for elite athletes. The startup remains in the pre-commercial stage but has attracted significant investor interest, with its valuation increasing rapidly as it expands research, product development, and hiring.
Temple Launches ESOP Liquidity Program
The employee liquidity initiative allows eligible staff to monetize part of their equity holdings while continuing to participate in Temple’s long-term growth.
According to the company:
- Current and former employees can sell a portion of vested ESOPs.
- The transaction values Temple at approximately $375 million.
- Employees will continue to retain ownership in the company after the partial liquidity event.
- The program is intended to recognize the contributions of early team members.
ESOP Program Snapshot
| Item | Details |
|---|---|
| Company | Temple |
| Founder | Deepinder Goyal |
| Current Valuation | Approximately $375 million |
| Program | ESOP Liquidity Event |
| Eligible Participants | Current and former employees |
| Objective | Allow employees to partially monetize vested equity |
Valuation Nearly Doubles
The liquidity event reflects Temple’s rapid increase in valuation.
Valuation Timeline
| Milestone | Valuation |
|---|---|
| Seed funding round (February 2026) | $190 million |
| ESOP liquidity program | $375 million |
Temple raised $54 million in its initial friends-and-family funding round earlier this year, backed by founder-investors, early Zomato supporters, venture capital firms, and more than 30 employees. The latest valuation indicates strong investor confidence in the startup’s technology roadmap despite the company not yet launching a commercial product.
Rewarding Early Employees
ESOP liquidity programs have become increasingly common among fast-growing startups, allowing employees to access part of the value they have helped create without requiring the company to go public.
Such programs can:
- Improve employee retention.
- Reward early team members.
- Reduce pressure for an immediate IPO.
- Help attract top engineering and product talent.
- Strengthen confidence in the company’s long-term prospects.
For Temple, the move signals management’s commitment to sharing value creation with employees while continuing to build the business independently.
Temple’s Long-Term Vision
Temple is developing an advanced wearable device designed to measure cerebral blood flow and other physiological signals that existing consumer wearables do not track. The startup is targeting elite athletes and high-performance users, with plans to expand its capabilities through continued research in computational neuroscience, embedded systems, and brain-computer interface technologies.
The company has also been expanding its engineering and research teams while gradually testing early versions of its wearable technology with a limited group of users before a broader commercial rollout.
Looking Ahead
Temple’s first ESOP liquidity program represents an important milestone in the startup’s evolution, giving employees an opportunity to realize part of the value created during its early growth while reaffirming investor confidence in the company’s long-term potential. The jump in valuation to approximately $375 million suggests continued optimism around Deepinder Goyal’s vision for next-generation health and performance wearables, even before the product reaches the broader market.
Looking ahead, Temple is expected to continue investing heavily in research, product development, and talent acquisition as it prepares for commercial launch. If the company successfully delivers differentiated wearable technology capable of measuring previously inaccessible physiological metrics, it could emerge as a notable player in the premium health-tech and sports performance market while setting the stage for future funding rounds or strategic partnerships.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
